2m 2m 2m 2m 2m 2m 2m
Puma Biotech (PBYI)
NASDAQ
$9.39-$0.45 (-4.57%)
Price as of Oct 02, 2026 4:54 PM EDT- $507.9MMarket Cap
- 88.51%1-Year Change
- BiotechnologyIndustry
Puma Biotech (PBYI)
$9.39-$0.45 (-4.57%)
PBYI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.84 | ||
Change | -$0.09 (-0.91%) | ||
Open | $9.84 | ||
High | $10.07 | ||
Low | $9.77 | ||
Previous Close | $9.93 | ||
Volume | 518,407 | ||
30-Day Average Volume | 320,663 | ||
1-Week Change | 0.20% | ||
1-Month Change | 5.24% | ||
1-Year Change | 88.51% | ||
3-Year Change | 274.14% | ||
5-Year Change | 52.09% | ||
Fundamentals | |||
Shares Outstanding | 51.6M | ||
Total Assets | $192.7M | ||
Market Cap | $507.9M | ||
Enterprise Value | $471.4M | ||
Period: QTR TTM FY | |||
Revenue | $53.6M | ||
Net Income | $8.2M | ||
Free Cash Flow | $1.6M | ||
EBIT | $8.2M | ||
EBITDA | $10.8M | ||
Net Working Capital | $95.2M | ||
EPS | $0.16 | ||
Enterprise Value/EBITDA | 44 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 4 | ||
P/E | 62 | ||
PEG | 0 | ||
Price/Free Cash Flow | 313 | ||
Price/Operating Cash Flow | 313 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue